Guardant Health Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Everyone, thanks for joining us on the first day of our Healthcare conference. I'm Tejas Savant, and I cover the Life Science Tools and Diagnostics Sector here at Morgan Stanley. Delighted to have Guardant join us today. And representing the company, we have Helmy Eltoukhy and AmirAli Talasaz, Co-CEOs; and Mike Bell, CFO. So welcome, gents.
Before we get started, just some important disclosures here. Please see the Morgan Stanley Research Disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales rep.
Questions & Answers
So maybe just to get started, it's been over 3 years, Helmy and AmirAli, since Guardant went public in the fall of 2018 and even longer since you launched G360. What has surprised you the most on the upside and on the downside as you've sought to commercialize liquid biopsy, first in therapy and now, of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
